“If this blog helped you out, don’t keep it to yourself—share the link on your socials!” 👍 “Like what you read? Spread the love and share this blog on your social media.” 👍 “Found this useful? Hit share and let your friends know too!” 👍 “If you enjoyed this post, please share the URL with your friends online.” 👍 “Sharing is caring—drop this link on your social media if it helped you.”

Monday, August 25, 2025

Otsuka Pharmaceutical Co.


Otsuka Pharmaceutical – Product Catalog (A–Z)

  • Abilify → Generic: aripiprazole → Indication: Schizophrenia, bipolar disorder, adjunctive treatment of depression, irritability in autism → Dose: Tabs 2–30 mg; ODT; oral solution; injection

  • Abilify Maintena → Generic: aripiprazole (long-acting injectable) → Indication: Schizophrenia, maintenance in bipolar I disorder → Dose: Prefilled syringe/vial 300 mg, 400 mg monthly IM

  • Abilify MyCite → Generic: aripiprazole with ingestible event marker (digital pill) → Indication: Schizophrenia, bipolar I, adjunctive MDD → Dose: Tablets 2–30 mg with sensor + patch system

  • Abilify Asimtufii → Generic: aripiprazole (long-acting every-2-month injection) → Indication: Schizophrenia, bipolar I → Dose: 720 mg, 960 mg prefilled syringe (q8w IM)

  • Busulfex → Generic: busulfan (IV) → Indication: Conditioning regimen prior to bone marrow transplantation (CML, AML) → Dose: Injection 6 mg/mL, dosed by BSA

  • Deltyba → Generic: delamanid → Indication: Multidrug-resistant tuberculosis (MDR-TB) → Dose: Tablets 50 mg

  • Jynarque (outside U.S.: Jinarc) → Generic: tolvaptan → Indication: Autosomal dominant polycystic kidney disease (ADPKD) → Dose: Tablets 15, 30, 60, 90 mg

  • Mikelan → Generic: carteolol hydrochloride → Indication: Hypertension, angina → Dose: Tablets 10 mg; ophthalmic drops 1%, 2% (for glaucoma/ocular hypertension)

  • Mucosta → Generic: rebamipide → Indication: Gastritis, gastric ulcers (mucosal protective agent) → Dose: Tablets 100 mg; ophthalmic suspension 2% (for dry eye)

  • Pletal → Generic: cilostazol → Indication: Intermittent claudication (peripheral arterial disease), secondary stroke prevention (in some markets) → Dose: Tablets 50 mg, 100 mg bid

  • Rexulti (co-marketed with Lundbeck) → Generic: brexpiprazole → Indication: Schizophrenia, adjunctive treatment of depression, agitation in Alzheimer’s (U.S. approval 2023) → Dose: Tablets 0.25–4 mg

  • Samsca → Generic: tolvaptan → Indication: Hyponatremia due to SIADH, heart failure, cirrhosis → Dose: Tablets 15 mg, 30 mg

  • Sprinkle (Japan only) → Generic: fingolimod derivatives, under development → Indication: Multiple sclerosis (pipeline; not globally marketed yet)

  • Uplizna (co-licensed) → Generic: inebilizumab-cdon → Indication: Neuromyelitis optica spectrum disorder (NMOSD) → Dose: IV infusion 300 mg


    • on

    No comments:

    Post a Comment

    Subscribe to: Post Comments (Atom)